NAFLD-non-alcoholic fatty liver disease, BMI-body mass index, CT-computed tomography, HDL-high-density lipoprotein, HOMA-IR-homeostatic model assessment-insulin resistance, PNPLA3 G-patatin-like phospholipase domain-containing protein 3 gene, TG-triglycerides, WC-waist circumference. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.